Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

LONDON MARKET CLOSE: FTSE 100 rises despite tariff worries; M&G shines

30th May 2025 17:05

(Alliance News) - The FTSE 100 outperformed in a mixed day for European equities, after the US Court of Appeals temporarily reinstated Donald Trump's tariffs. Read More

Danaher partners with AstraZeneca to develop AI diagnostics

30th May 2025 10:08

(Alliance News) - Danaher Corp on Thursday said it has entered a partnership with AstraZeneca PLC to develop and commercialise tools and tests for precision medicine treatments, including artificial intelligence algorithms. Read More

Angle shares fall on weak 2025 outlook despite narrower annual loss

28th May 2025 13:31

(Alliance News) - Angle PLC on Wednesday said its annual loss narrowed in 2024 as revenue rose and operating costs fell, though the company warned that market uncertainty and funding cuts were weighing on revenue so far this year. Read More

LONDON BROKER RATINGS: RBC cuts National Grid; Citigroup cuts South32

28th May 2025 09:36

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON MARKET CLOSE: Tariff optimism, US data lifts FTSE 100

27th May 2025 17:10

(Alliance News) - Stock prices in Europe ended largely higher on Tuesday, building on a confident start to the week, while equities in London also got in on the action following Monday's public holiday. Read More

AstraZeneca bladder cancer drug Imfinzi recommended for EU approval

27th May 2025 08:36

(Alliance News) - AstraZeneca PLC on Tuesday said its Imfinzi, or durvalumab, therapy has been recommended for approval in the EU for the treatment of muscle-invasive bladder cancer. Read More

LONDON BRIEFING: Bodycote revenue falls; Inspired mulls possible offer

27th May 2025 07:56

(Alliance News) - London's FTSE 100 is called higher on Tuesday following a bank holiday-lengthened weekend, as Nato members are expected to raise defence spending to 5% of output. Read More

IN BRIEF: AstraZeneca chief executive joins Agilent Technologies board

21st May 2025 14:28

AstraZeneca PLC - Cambridge-based pharmaceutical and biotechnology company - Says Chief Executive Officer Pascal Soriot has been appointed a director of Santa Clara, California-based laboratory software and services company Agilent Technologies Inc, effective immediately. Read More

AstraZeneca completes EsoBiotec acquisition for up to USD1 billion

20th May 2025 08:55

(Alliance News) - AstraZeneca PLC on Tuesday said it has completed its acquisition of Belgian biotechnology firm EsoBiotec SA, bolstering its cell therapy capabilities with a platform that could significantly accelerate cancer treatment delivery. Read More

IN BRIEF: AstraZeneca trial shows Airsupra effective against asthma

19th May 2025 19:54

AstraZeneca PLC - Cambridge-based pharmaceutical and biotechnology company - Phase 3b Batura trial shows statistically significant and clinically meaningful improvements in mild asthma in patients treated with Airsupra (albuterol and budesonide) than albuterol alone. Compared to placebo, Airsupra significantly reduces the risk of a severe symptom exacerbation by 47%. Patients treated with airsupra have 63% lower exposure to total systemic corticosteroids over the treatment period compared with albuterol-alone, reducing risks from cumulative exposure to SCS which include type 2 diabetes, depression and anxiety, renal impairment, cataracts, cardiovascular disease, pneumonia and fractures. Read More

LONDON MARKET CLOSE: Stocks rise amid trade de-escalation boost

16th May 2025 17:01

(Alliance News) - The FTSE 100 pushed higher on Friday, ending the week on a strong note, and now at the level it roughly stood at prior to US President Donald Trump's 'liberation day' tariff melee. Read More

LONDON MARKET MIDDAY: FTSE 100 outperforms as Europe underwhelms

15th May 2025 12:13

(Alliance News) - London's FTSE 100 outperformed European peers, though a share price fall for oil majors and a host of other shares that went ex-dividend kept a lid on the blue-chip index's progress. Read More

AstraZeneca gets UK approval for Trixeo with eco-friendly propellant

12th May 2025 09:09

(Alliance News) - AstraZeneca PLC on Monday announced that its medicine Trixeo Aerosphere has been approved by the UK Medicines & Healthcare Products Regulatory Agency with "an innovative, next-generation propellant with near-zero global warming potential". Read More

LONDON MARKET OPEN: Europe green on US-China deal to suspend tariffs

12th May 2025 09:03

(Alliance News) - London opened in the green on Monday, as the US and China agree a 90-day pause on tariffs and the UK prepares to host European ministers for talks on Russia. Read More

AstraZeneca receives positive bladder cancer trial data for Imfinzi

9th May 2025 09:29

(Alliance News) - AstraZeneca PLC on Friday said it has received positive data from a trial evaluating Imfinzi as a treatment for patients with high-risk non-muscle-invasive bladder cancer. Read More

LONDON MARKET OPEN: Fed supports dollar; UK PM to make trade update

8th May 2025 09:01

(Alliance News) - European stocks opened higher on Thursday, with the FTSE 100 registering only a minor gain, however, as investors digest Wednesday's Federal Reserve decision and look ahead to a probable Bank of England rate cut. Read More

LONDON MARKET CLOSE: FTSE 100 ends winning run ahead of Fed rate call

7th May 2025 17:01

(Alliance News) - The FTSE 100 ended a 16-day winning streak on Wednesday, ahead of interest rate decisions in the US and UK, weighed by weak pharmaceutical and telecoms stocks. Read More

LONDON MARKET MIDDAY: Stocks decline before central bank decisions

7th May 2025 12:07

(Alliance News) - Stock prices in London were weaker on Wednesday, with some pre-Federal Reserve decision nerves and geopolitical tensions hurting sentiment. Read More

AstraZeneca touts positive trial data for breast cancer treatment

7th May 2025 09:33

(Alliance News) - AstraZeneca PLC on Wednesday said it has received positive high-level results from its latest trial evaluating Enhertu in patients with high-risk, locally advanced HER2-positive early-stage breast cancer. Read More

LONDON MARKET OPEN: European shares struggle despite US-China hope

7th May 2025 08:52

(Alliance News) - London's FTSE 100 gave back a fraction of its recent progress early Wednesday, despite some optimism on the tariff front, ahead of a US interest rate decision later. Read More

FTSE 100 Latest
Value8,772.38
Change55.93